Christopher Price, MD
Anesthesiology · Norfolk, NENPI 1205887510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Abbott at 29.3% of the total. Among anesthesiology clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$774
- Boston Scientific$446
- AbbVie$297
- Si-bone, Inc.$196
- Biohaven Pharmaceutical Holding Company Ltd.$168
- Saluda Medical Americas, Inc.$101
- plus $655 from 17 others
What the payments were for
- Food & beverage$2,638100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 51 | $774 |
| Boston Scientific | 26 | $446 |
| AbbVie(2 entities) | 18 | $297 |
| Si-bone, Inc. | 9 | $196 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $168 |
| Saluda Medical Americas, Inc. | 6 | $101 |
| Forte Bio-pharma LLC | 5 | $85 |
| Nevro Corp. | 3 | $61 |
| GRT US Holding, Inc. | 4 | $60 |
| Daiichi Sankyo Inc. | 5 | $58 |
| MML US, Inc. | 2 | $51 |
| Globus Medical | 2 | $48 |
| Pfizer | 3 | $41 |
| Biodelivery Sciences International, Inc. | 3 | $38 |
| Medtronic(2 entities) | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Scilex Pharmaceuticals Inc. | 2 | $30 |
| Lilly USA, LLC | 2 | $26 |
| Collegium Pharmaceutical, Inc. | 2 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Covidien LP | 1 | $18 |
| Conetic Solutions, Inc. | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $12 |
How this compares
$2,638 in reported general payments places this provider in the 90th percentile of 281 anesthesiology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 15 | $8,707 |
| Fentanyl | 65 | $6,303 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 253 | $5,076 |
| OxycontinOxycodone Hcl | 12 | $4,144 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 77 | $1,517 |
| Gabapentin | 99 | $1,102 |
| Tramadol Hcl | 158 | $933 |
| Morphine Sulfate ErMorphine Sulfate | 33 | $886 |
| Oxycodone Hcl | 48 | $580 |
| Nitroglycerin PatchNitroglycerin | 12 | $293 |
| Morphine Sulfate | 12 | $183 |
| Methadone Hcl | 11 | $154 |
| Cyclobenzaprine Hcl | 19 | $150 |
| Amitriptyline Hcl | 14 | $137 |
| Potassium Chloride | 13 | $113 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $25 | $8,70715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 281 anesthesiology providers in Nebraska.
Other anesthesiology in Norfolk
- Myles GartNorfolk$115K
- Merlin WehlingKearney$2.7M
- Kenneth GrossLincoln$153K
- Douglas SpurgeonLincoln$101K
- Travis TeetorOmaha$82K
- Burt McKeagKearney$13K
- Redgy FullerOmaha$9K
- Peter PellegrinoOmaha$9K
- Robert MuellemanOmaha$9K
- Kristina BirchOmaha$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.